Physician profile
Jeffrey D Reese
NPI 1811486566
$58,602.64
in general payments reported to CMS, 2019-2025
14 companies · $3,130 in 2025
The $3,130 reported for 2025 was more than what 77% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $391 · 2023: $52K · 2024: $3,049 · 2025: $3,130.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $50K · Travel and Lodging: $6,700 · Food and Beverage: $1,512.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $50,000.00 |
| Travel and Lodging | $6,700.00 |
| Food and Beverage | $1,512.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $50,293.48 | 2023-2025 | Cd Horizon Spinal System, Intellis Adaptivestim, Mazor X System |
| Globus Medical, INC. | $3,939.27 | 2024-2025 | Xlif, Senza, Omnia |
| Medical Device Business Services, INC. | $1,876.74 | 2023 | Symphony |
| Synthes Gmbh | $1,655.91 | 2024 | |
| Stryker Corporation | $500.32 | 2022-2025 | Gamma, Triathlon, Axsos |
| Alon Medical Technology | $100.20 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $55.02 | 2024-2025 | |
| Depuy Synthes Sales INC. | $53.04 | 2023-2024 | Teligen, Fibergraft Bg Morsels, Sentio |
| Pacira Pharmaceuticals Incorporated | $35.79 | 2024 | Zilretta, Iovera |
| Djo, LLC | $34.48 | 2024-2025 | Cmf |
| Orthofix Medical, INC. | $27.29 | 2025 | Spinal-Stim, Cervical-Stim |
| Skeletal Dynamics INC | $14.61 | 2024-2025 | Ijs, Implate, Align |
| Spineology INC. | $8.80 | 2025 | |
| Biocomposites INC | $7.69 | 2025 | Stimulan |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Reese listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.